Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMDZ $22.69 1.6900 +8.05%
APRI $1.22 0.0700 +6.09%
IDRA $3.90 0.2202 +5.98%
SNSS $1.00 0.0520 +5.47%
PVCT $0.45 0.0200 +4.65%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

AEZS $9.50 -1.5600 -14.10%
KBIO $32.52 -2.3099 -6.63%
CYTK $11.67 -0.3500 -2.91%
CLVS $31.35 -0.8700 -2.70%
TEVA $61.94 -1.5300 -2.41%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Former Health Secretary Andrew Lansley Takes On Roche Advisory Role

(Pharmafile [UK]) Nov 16, 2015 - Former UK health secretary Andrew Lansley has taken on work as an advisor to Roche in the midst of ongoing controversy over drug pricing and the future of the Cancer Drugs Fund (CDF).
read article 

New York Businessman Grants Millions To MD Anderson

(Houston Business Journal) Nov 16, 2015 - Andrew Sabin, a New York-based businessman and philanthropist, committed $30 million to support cancer research at the University of Texas MD Anderson Cancer Center.
read article 

US Oncology Research Recognizes Outstanding Investigators And Oncology Practices For Their Contributions To Clinical Research By Launching The Prestigious Centum Club

(The US Oncology Network) Nov 16, 2015 - 14th Annual Science Forum promotes excellence in clinical research, honors leading researchers.
read corporate press release 

Found Too Late: Cancer Preys On Rural Americans

(USA Today) Nov 12, 2015 - Getting preventive screenings, quality treatment is much tougher for people who struggle to get by.
read article 

France's Mauna Kea Eyes Surgical Technology Partnership By End 2015

(Reuters) Nov 13, 2015 - French medical technology company Mauna Kea could sign a partnership by the end of the year that would allow it to accelerate the commercial development of a small microscope approved by U.S. regulators for use in surgical procedures to diagnose cancer, its chief executive told Reuters.
read article 

Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer

(Vigilant Biosciences) Nov 16, 2015 - First and only test to detect a tumor-initiating stem cell biomarker for head and neck cancer.
read corporate press release 

TESARO Announces the Launch of VARUBI(TM) (Rolapitant) in the United States

(Morningstar) Nov 16, 2015 - TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that VARUBI™ (rolapitant), an NK-1 receptor antagonist, is now available in the United States.
read article 

Array BioPharma And Pierre Fabre Announce Development And Commercialization Collaboration For Two Novel Oncology Products, Binimetinib And Encorafenib

(Array BioPharma) Nov 16, 2015 - Array BioPharma Inc. and Pierre Fabre today announced a collaboration to globally develop and commercialize Array's late-stage novel oncology products, binimetinib and encorafenib.
read corporate press release 

Study Shows Castle Biosciences’ DecisionDx-UM is Highly Effective at Predicting Metastatic Risk in Patients with Eye Cancer

(Castle Biosciences) Nov 16, 2015 - Castle Biosciences, Inc. today announced new study results of the Company’s DecisionDx-UM gene expression profile test, verifying that the assay is highly effective at identifying uveal melanoma tumors at high risk of metastasis.
read corporate press release 

Cellceutix Selects Docetaxel for Combination Arm in Planned Phase 2 Trial for Ovarian Cancer

(Yahoo! Finance) Nov 16, 2015 - Cellceutix Corporation today reports that, based upon ongoing laboratory studies, the Company intends to use docetaxel for the combination therapy arm in the planned Phase 2 clinical trial to treat patients with platinum-resistance ovarian cancer.
read article 

EMUC15: Study Shows Prostate Cancer Screening Under Age Of 55 May Be Of Limited Value

(EAU) Nov 14, 2015 - Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after the age of 55, according to a new 20 year analysis of 6822 patients, presented at the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15) in Barcelona.
read press release 

Biomarkers May Help Predict Treatment Response in mRCC

(Medscape Medical News) Nov 13, 2015 - Patients with metastatic renal cell carcinoma (mRCC) have variable clinical outcomes to treatment, and identifying the underlying molecular markers may help predict response to therapy.
read article (free registration required) 

Momenta Pauses Enrollment In Necuparanib Trial

(BioCentury) Nov 13, 2015 - Momenta Pharmaceuticals Inc. said it temporarily paused enrollment in the Phase II portion of a Phase I/II trial of necuparanib (M402) to treat metastatic pancreatic cancer.
read article 

Gilead's Zydelig® Combined with Bendamustine and Rituximab Shows Superior Efficacy to Bendamustine/Rituximab in Phase 3 Study of Patients with Relapsed Chronic Lymphocytic Leukemia

(Morningstar) Nov 16, 2015 - Gilead’s Zydelig® combined with bendamustine and rituximab shows superior efficacy to bendamustine/rituximab in phase 3 study of patients with relapsed chronic lymphocytic leukemia; interim analyses results from study 115 to be presented as a late-breaking abstract at the American Society of Hematology (ASH) Annual Meeting.
read article 

Clovis Craters on Lung Cancer Drug-Review Delay

(TheStreet) Nov 16, 2015 - Clovis Oncology must submit additional clinical data on its targeted lung cancer drug rociletinib to U.S. regulators, delaying the approval review and putting the company further behind rival AstraZeneca, whose competing lung cancer drug Tagrisso was approved on Friday, Nov. 13.
read article 

NIH Cancer Therapy Trial May Raise Hopes for Celgene, Bluebird

(Bloomberg) Nov 16, 2015 - A U.S. National Institutes of Health trial of a genetically engineered T-cell therapy resulted in some remissions in patients with advanced blood cancer, a promising sign for the approach that also is being pursued by drugmakers Celgene Corp. and Bluebird Bio Inc.
read article 

U.S. FDA Approves Gilead's Hepatitis C Drug for Expanded Use

(Reuters) Nov 12, 2015 - Drugmaker Gilead Sciences Inc said on Thursday the U.S. Food and Drug Administration had approved the expanded use of its blockbuster hepatitis C drug, Harvoni.
read article 

Perrigo's Shareholders Reject Mylan Takeover Bid

(CNBC) Nov 13, 2015 - Shares of over-the-counter drugmaker Perrigo sank early Friday after its stock owners rejected a hostile, $26 billion takeover bid from Mylan.
read article 

Uterus Transplants May Soon Help Some Infertile Women in the U.S. Become Pregnant

(New York Times) Nov 12, 2015 - Surgeons at the Cleveland Clinic are set to become the first in the United States to transplant a uterus.
read article 

TAGRISSO™ (AZD9291) Approved by the US FDA for Patients with EGFR T790M Mutation-Positive Metastatic Non-Small Cell Lung Cancer

(AstraZeneca) Nov 13, 2015 - AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO™ (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
read corporate press release 

U.S. Smoking Rate Declines, but Poor Remain at Higher Risk

(New York Times) Nov 12, 2015 - Smoking, the leading cause of preventable death in the United States, continued to decline last year, federal health authorities reported Thursday, with the share of American adults who smoke dropping to 16.8 percent, down from 17.8 percent in 2013.
read article 

ASCO Sends Letter of Support for the TRUST IT Act

(ASCO in Action) Nov 12, 2015 - On November 9, ASCO sent a letter of support to Sens. Bill Cassidy, MD (R-La.) and Sheldon Whitehouse (D-R.I.) for S.2141,the Transparent Ratings on Usability and Security to Transform Information Technology Act of 2015 (TRUST IT).
read press release 

ASCO in Action Brief: MACRA

(ASCO in Action) Nov 13, 2015 - The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) passed earlier this year, effectively repealing the sustainable growth rate (SGR) and introducing comprehensive changes in how Medicare pays physicians for services.
read press release 

Ruling Delayed on Cancer Patient's Request That Would Let Her Buy Medical Marijuana Earlier

(US News & World Report/Associated Press) Nov 12, 2015 - Linda Horan, diagnosed in July with late-stage lung cancer, says she may be dead before New Hampshire opens its first medical marijuana dispensaries early next year.
read article 

Georgia Health Agency Shelves CTCA Exemption

(Atlanta Business Chronicle) Nov 12, 2015 – The Georgia Department of Community Health has withdrawn a proposal to remove a cap on patients served by Cancer Treatment Centers of America’s hospital in Newnan, Ga.
read article